Palmarosa essential oil (PEO) is an alternative to synthetic fungicides to control the contamination by food-deteriorating fungi, such as Aspergillus nomius. Nonetheless, the low long-term stability and volatility hamper its utilization. Thus, this study aimed to develop nanostructured lipid carriers (NLCs) containing PEO to improve its stability and consequently prolong the activity against A. nomius. A mixture design was applied to find the best preparation conditions for antifungal activity. The characterization analyses included size measurements, zeta potential (ζ-potential), entrapment efficiency (EE), and antifungal activity (by inhibition of mycelial growth (IMG) and/or in situ test (pre-contaminated Brazil nuts) tests). The nanocarriers presented particle sizes smaller than 300 nm, homogeneous size distribution, ζ-potential of −25.19 to −41.81 mV, and EE between 73.6 and 100%. The formulations F5 and F10 showed the highest IMG value (98.75%). Based on the regression model, three optimized formulations (OFs) were tested for antifungal activity (IMG and in situ test), which showed 100% of inhibition and prevented the deterioration of Brazil nuts by A. nomius. The preliminary stability test showed the maintenance of antifungal activity and physicochemical characteristics for 90 days. These results suggest a promising system as a biofungicide against A. nomius.

Leishmaniasis is a disease caused by protozoa species of the Leishmania genus, and the current treatments face several difficulties and obstacles. Most anti-leishmanial drugs are administered intravenously, showing many side effects and drug resistance. The discovery of new anti-leishmanial compounds and the development of new pharmaceutical systems for more efficient and safer treatments are necessary. Copaiba oil-resin (CO) has been shown to be a promising natural compound against leishmaniasis. However, CO displays poor aqueous solubility and bioavailability. Self-emulsifying drug delivery systems (SEDDS) can provide platforms for release of hydrophobic compounds in the gastrointestinal tract, improving their aqueous solubilization, absorption and bioavailability. Therefore, the present work aimed to develop SEDDS containing CO and Soluplus^® surfactant for the oral treatment of leishmaniasis. The design of the systems was accomplished using ternary phase diagrams. Emulsification and dispersion time tests were used to investigate the emulsification process in gastric and intestinal environments. The formulations were nanostructured and improved the CO solubilization. Their in vitro antiproliferative activity against promastigote forms of L. amazonensis and L. infantum, and low in vitro cytotoxicity against macrophages were also observed. More studies are necessary to determine effectiveness of SOL in these systems, which can be candidates for further pharmacokinetics and in vivo investigations.

Copaiba oil (CO) is an oleoresin containing resinous acids, comprising mainly of diterpenes, and volatile compounds, comprising of sesquiterpenes. CO has been used for many years as a therapeutic agent and cosmetic, being the β-caryophyllene (CAR) one of the main sesquiterpene markers found in CO samples. During the last years, some analytical methods have been developed for analysis of sesquiterpenes like CAR from CO. However, these methods are based on gas chromatography, and requiring additional steps, such as derivatization or extraction of the essential fraction of the CO for sesquiterpenes analysis. Liquid chromatography methodologies have been proposed only for analysis of diterpenes. Therefore, the aim of this study was to develop a high-performance liquid chromatography (HPLC) assay for CAR analysis in CO samples (Copaifera reticulata Ducke) and in emulsion systems containing CO. The HPLC system suitability was determined through the capacity factor, repeatability, relative retention, resolution, tailing factor, theoretical plate number and the height of the theoretical plate; where the method developed showed the efficiency for separation of CO compounds. The method was validated displaying specificity, linearity, precision, accuracy, and robustness. Moreover, it showed to be of utmost importance to analyze CO in emulsion systems, displaying versatile and applicability.

Omeprazole (OM), a temperature, pH, and moisture-sensitive drug, poses formulation challenges. This study delves into the complex development of OM pellets, focusing on the impact of buffering excipients on stability and release. Addressing the challenges of OM pellet stability requires a comprehensive compatibility and stress study involving key excipients. Binary mixtures of OM with dibasic sodium phosphate dihydrate (DSPD), mannitol, hypromellose (Hyp), and polysorbate underwent scrutiny for possible incompatibilities, subjected to 40°C stress and 75% relative humidity. DSC, TGA, and ATR-FTIR analyses were conducted, with quantitative monitoring of OM by HPLC. Formulations with varied proportions of DSPD and Hyp were also stress-tested. While all excipients exhibited compatibility with OM, thermal analysis suggested a potential incompatibility between OM and mannitol, disproven by HPLC. Stress tests on diverse formulations confirmed their adequacy, maintaining OM content and impurities within acceptable limits. Increased Hyp reduced impurities, and its combination with DSPD further enhanced stability. The study concludes that augmenting DSPD with Hyp offers effective protection for OM pellets, ensuring their stability.